Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR9.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR2.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR1.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR4.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR3.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR5.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR7.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR6.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR22.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR23.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR13.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR24.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR17.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR11.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR19.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR15.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR27.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR12.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR14.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR25.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR16.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR26.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR10.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR18.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR20.htm
EX-10.1 - EXHIBIT 10.1 - HEALTH DISCOVERY CORPex10-1.htm
EX-32.1 - EXHIBIT 32.1 - HEALTH DISCOVERY CORPex32-1.htm
EX-10.2 - EXHIBIT 10.2 - HEALTH DISCOVERY CORPex10-2.htm
EX-31.1 - EXHIBIT 31.1 - HEALTH DISCOVERY CORPex31-1.htm
10-Q - FORM 10-Q - HEALTH DISCOVERY CORPt74989_10q.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR21.htm
v2.4.0.6
NET INCOME (LOSS) PER SHARE
9 Months Ended
Sep. 30, 2012
Earnings Per Share [Abstract]  
NET INCOME (LOSS) PER SHARE
Note C - NET INCOME (LOSS) PER SHARE
 
Basic Earnings Per Share (“EPS”) includes no dilution and is computed by dividing income or loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of securities that could share in the earnings or losses of the entity.
 
Due to the net loss for the three and nine month periods ending September 30, 2011 the calculation of diluted per share amounts would create an anti-dilutive result and therefore are not presented.
 
The following is an analysis of the basic and diluted earnings per common share computations for the three and nine months ended September 30, 2012:
 
Three months ended
September 30,2012
Nine months ended
September 30,2012
Basic:
Net income attributable to common shareholders
$ 1,448,315 $ 240,237
Basic weighted average common shares outstanding
232,457,588 231,907,958
Basic earnings per common share
$ 0.006 $ 0.001
Diluted:
Net income attributable to common shareholders
$ 1,483,280 $ 240,237
Basic weighted average common shares outstanding
232,457,588 231,907,958
Effect of dilutive securities:
Conversion of options and warrants
28,954 615,362
Conversion of preferred shares to common shares
17,340,175 -
Diluted weighted average common shares outstanding
249,826,717 232,523,320
Diluted earnings per common share
$ 0.006 $ 0.001
 
During the three and nine month periods ended September 30, 2012, 6,500,000 outstanding stock options and warrants were not included in the computation of diluted earnings per common share because to do so would have an antidilutive effect. In addition, for the nine month period ended September 30, 2012, 17,340,175 in convertible preferred stock was not included in the diluted earnings per common share calculation because to do so would have had an antidilutive effect.